1 |
SHORT M W, BURGES K G, FRY V T. Esophageal cancer [J].Am, Fam Physician,2017, 95(1): 22-28.
|
2 |
ROSENBERG S A. Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment[J]. Nat Rev Clin Oncol,2014,11(11):630-632.
|
3 |
YUAN X, ZHANG A Z, REN Y L, et al. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: a meta-analysis[J].Medicine (Baltimore), 2021, 100(13): e24519.
|
4 |
LAN L, ZHAO F, CAI Y, et al. Epidemiological analysis on mortality of cancer in China, 2015[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2018, 39(1): 32-34.
|
5 |
王艺静, 常志伟, 秦艳茹.晚期食管癌分子靶向治疗研究进展[J].河南医学研究, 2017, 26(9):1596-1598.
|
6 |
陈志明, 薛 强, 陈晓珏,等.同步加量调强放疗联合尼妥珠单抗治疗局部晚期食管癌[J].中华医学杂志,2016, 96(8):640-642.
|
7 |
李丹波.放疗联合靶向药物治疗食管癌患者的疗效[J].当代医学,2019,25(21):135-137.
|
8 |
BUSUND L T, OW K T, RUSSELL P,et al.Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential[J].Virchows Arch,2004,444(2):142-148.
|
9 |
孙 卉,钱亚云.胰岛素样生长因子系统和EMT在胃癌中作用的研究进展[J].中国肿瘤生物治疗杂志,2019,26(7):823-827.
|
10 |
POLLAK M.Insulin-like growth factor-related signaling and cancer development[M]//Cancer Prevention. Berlin, Heidelberg: Springer Berlin Heidelberg,2007,174:49-53.
|
11 |
HÖPFNER M, BARADARI V, HUETHER A,et al.The insulin-like growth factor receptor Ⅰ is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours[J]. Endocr Relat Cancer, 2006, 13(1): 135-149.
|
12 |
KAULFUSS S, BURFEIND P, GAEDCKE J,et al.Dual silencing of insulin-like growth factor-Ⅰ receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis[J]. Mol Cancer Ther,2009,8(4): 821-833.
|
13 |
GARCÍA-ECHEVERRÍA C, PEARSON M A, MARTI A,et al. In vivo antitumor activity of NVP-AEW541-A novel,potent,and selective inhibitor of the IGF-IR kinase[J].Cancer Cell,2004,5(3):231-239.
|
14 |
KIRSCHNER L S.Emerging treatment strategies for adrenocortical carcinoma:a new hope[J].J Clin Endocrinol Metab,2006,91(1):14-21.
|
15 |
TARN C, RINK L, MERKEL E, et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors[J]. PNAS, 2008,105(24):8387-8392.
|
16 |
MOSER C, SCHACHTSCHNEIDER P, LANG S A,et al.Inhibition of insulin-like growth factor-Ⅰ receptor (IGF-ⅠR) using NVP-AEW541,a small-molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis[J]. Eur J Cancer,2008,44(11): 1577-1586.
|
17 |
HÖPFNER M, HUETHER A, SUTTER A P,et al.Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells[J]. Biochem Pharmacol,2006,71(10):1435-1448.
|
18 |
ALL-ERICSSON C, GIRNITA L, SEREGARD S,et al. Insulin-like growth factor-Ⅰ receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target[J]. Investig Ophthalmol Vis Sci,2002,43(1):1-8.
|
19 |
IANZA A, SIRICO M, BERNOCCHI O,et al. Role of the IGF-1 axis in overcoming resistance in breast cancer [J]. Front Cell Dev Biol, 2021, 9: 641449.
|
20 |
HU G F, WANG C, HU G X, et al. AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway[J]. Ann Transl Med, 2020, 8(6):336.
|
21 |
周 楠,回丽敏,刘振兴,等.IGF-1R抑制剂NVP-AEW541对卵巢癌移植瘤中休眠细胞的作用[J].肿瘤,2018,38(10):942-950.
|
22 |
张庆慧,刘晓波,李胜保,等.食管癌的发病现状及趋势分析[J].湖北医药学院学报,2019,38(2):192-196.
|
23 |
黄 莉,王东峰,李洪霖,等.内镜下ESD治疗早期食管癌的有效性、安全性[J].中国老年学杂志,2019,39(7):1580-1583.
|
24 |
ALSOP B R, SHARMA P.Esophageal cancer[J].Gastroenterol Clin N Am,2016,45(3):399-412.
|
25 |
ILSON D H.Adenocarcinoma of the esophagus:Controversies and consensus[J].Chin Clin Oncol,2017,6(5):52.
|
26 |
孟茜茜,张子凡,程志远,等.食管癌肿瘤标志物研究及临床应用进展[J].中国实用内科杂志,2019,39(7):634-639.
|
27 |
张子凡,程志远,孟茜茜,等.食管癌多器官转移预后分析与列线图的建立[J].中国实用内科杂志,2019,39(7):607-612.
|
28 |
代林睿,汤凤玲.放疗联合靶向药物治疗食管癌的研究进展[J].名医,2019(8):100.
|
29 |
DUBECZ A, MOLENA D, PETERS J H. Modern surgery for esophageal cancer[J]. Gastroenterol Clin N Am, 2008, 37(4): 965-987.
|
30 |
孙俊锋.Cytohesin分子在结直肠癌EGFR及IGFR分子通路中激活作用研究[D].杭州: 浙江大学, 2013.
|
31 |
PARK J H, CHOI Y J, KIM S Y,et al. Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rdgeneration EGF receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer[J]. Oncotarget,2016,7(16):22005-22015.
|